![](https://tracker.live.rns-distribution.com/track.live-rns/5314904_d9353a075fe0b610698e373da828b7e4.png)
20 August 2024
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Notice of Results
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, will announce its unaudited interim results for the six months ended 30 June 2024 on Thursday 22 August 2024.
Enquiries:
| |
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit: https://cambridgecognition.com/
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.